Sensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan

AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakh...

Full description

Saved in:
Bibliographic Details
Published inOpen access Macedonian journal of medical sciences Vol. 5; no. 1; pp. 6 - 8
Main Authors Azizov, Ilya S., Lavrinenko, Alyona V., Belyaev, Ilya A., Babenko, Dmitry B., Shambilova, Natalya A., Bissenova, Nelya M.
Format Journal Article
LanguageEnglish
Published Macedonia ID Design 2012/DOOEL Skopje 15.03.2017
Subjects
Online AccessGet full text
ISSN1857-9655
1857-9655
DOI10.3889/oamjms.2017.023

Cover

Loading…
Abstract AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTS: All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSION: Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin.
AbstractList The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs. The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits. All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin. Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin.
AIMThe article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODSThe strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTSAll identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSIONThus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin.
AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTS: All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSION: Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin.
Author Azizov, Ilya S.
Shambilova, Natalya A.
Lavrinenko, Alyona V.
Belyaev, Ilya A.
Babenko, Dmitry B.
Bissenova, Nelya M.
AuthorAffiliation 1 Institute of Antimicrobial Hemotherapy, Smolensk, Russia
2 Karaganda State Medical University, National Scientific Medical Center, Karaganda, Kazakhstan
AuthorAffiliation_xml – name: 1 Institute of Antimicrobial Hemotherapy, Smolensk, Russia
– name: 2 Karaganda State Medical University, National Scientific Medical Center, Karaganda, Kazakhstan
Author_xml – sequence: 1
  givenname: Ilya S.
  surname: Azizov
  fullname: Azizov, Ilya S.
– sequence: 2
  givenname: Alyona V.
  surname: Lavrinenko
  fullname: Lavrinenko, Alyona V.
– sequence: 3
  givenname: Ilya A.
  surname: Belyaev
  fullname: Belyaev, Ilya A.
– sequence: 4
  givenname: Dmitry B.
  surname: Babenko
  fullname: Babenko, Dmitry B.
– sequence: 5
  givenname: Natalya A.
  surname: Shambilova
  fullname: Shambilova, Natalya A.
– sequence: 6
  givenname: Nelya M.
  surname: Bissenova
  fullname: Bissenova, Nelya M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28293307$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v1DAQhi1URD_omRvykUu2_sCJc0FaLYVWFIEonK3ZeNL1kthb26lofwM_Gi9bqoLEySPP874zmveQ7PngkZAXnM2k1u1JgHE9pplgvJkxIZ-QA65VU7W1UnuP6n1ynNKaMcZVW3MhnpF9oUUrJWsOyM9L9Mlld-PyLc2Bzn12o-tiWDoY6Ns4XSUaevo54WTDGDwkOsfy63xIQE9_5IgjVl8wuZTBZ3qZIzif6HkKA2S01HmaV0g_wjpEehbSxmUYfnsu0Bd4oB_gDr6vtvLn5Glfmnh8_x6Rb-9Ovy7OqotP788X84uqk0zLquMaa9tYzpRSgnfWtl3fSqZqpZkFEFYqUK-ZlMAR1LJrarnsm8ZiacpeySPyZue7mZYj2m63iNlEN0K8NQGc-bvj3cpchRujpGC61cXg1b1BDNcTpmxGlzocBvAYpmS4bhpd4FoU9OXjWQ9D_kRQgJMdUI6eUsT-AeHMbHM2u5zNNmdTci4K9Y-iK0fNLmyXdcN_db8ALSayog
CitedBy_id crossref_primary_10_1371_journal_pone_0307784
crossref_primary_10_36488_cmac_2022_3_254_260
Cites_doi 10.1371/journal.pone.0123690
10.1111/j.1365-2885.2005.00666.x
10.1111/j.1469-0691.2011.03570.x
10.1093/clinids/24.Supplement_1.S157
10.2217/17460913.2.5.501
10.1016/S1473-3099(13)70168-3
10.1586/eri.09.108
10.2217/fmb.15.48
10.1128/JCM.38.1.40-43.2000
10.3389/fpubh.2014.00145
10.1111/j.1574-6976.2011.00268.x
10.1111/joim.12342
10.1016/j.jcf.2016.08.005
ContentType Journal Article
Copyright Copyright: © 2017 Ilya S. Azizov, Alyona V. Lavrinenko, Ilya A. Belyaev, Dmitry B. Babenko, Natalya A. Shambilova, Nelya M. Bissenova. 2017
Copyright_xml – notice: Copyright: © 2017 Ilya S. Azizov, Alyona V. Lavrinenko, Ilya A. Belyaev, Dmitry B. Babenko, Natalya A. Shambilova, Nelya M. Bissenova. 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.3889/oamjms.2017.023
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1857-9655
EndPage 8
ExternalDocumentID PMC5320898
28293307
10_3889_oamjms_2017_023
Genre Journal Article
GroupedDBID 53G
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
C~G
DYU
HYE
IPNFZ
KQ8
M48
M~E
OK1
PGMZT
RIG
RPM
SLJYH
GROUPED_DOAJ
NPM
7X8
ABFKT
5PM
ID FETCH-LOGICAL-c3083-c18e6d7d1055521cdd9cf93056580daa2d35a54033a1ea5bc763bf77dedaa3f53
IEDL.DBID M48
ISSN 1857-9655
IngestDate Thu Aug 21 18:31:32 EDT 2025
Thu Sep 04 20:02:02 EDT 2025
Thu Jan 02 22:21:46 EST 2025
Tue Jul 01 03:04:23 EDT 2025
Thu Apr 24 23:08:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Keywords Pseudomonas aeruginosa
VIM
MALDI-TOF
carbapenemases gene
Antibiotic resistance
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3083-c18e6d7d1055521cdd9cf93056580daa2d35a54033a1ea5bc763bf77dedaa3f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3889/oamjms.2017.023
PMID 28293307
PQID 1877853262
PQPubID 23479
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5320898
proquest_miscellaneous_1877853262
pubmed_primary_28293307
crossref_primary_10_3889_oamjms_2017_023
crossref_citationtrail_10_3889_oamjms_2017_023
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-Mar-15
PublicationDateYYYYMMDD 2017-03-15
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-Mar-15
  day: 15
PublicationDecade 2010
PublicationPlace Macedonia
PublicationPlace_xml – name: Macedonia
– name: Republic of Macedonia
PublicationTitle Open access Macedonian journal of medical sciences
PublicationTitleAlternate Open Access Maced J Med Sci
PublicationYear 2017
Publisher ID Design 2012/DOOEL Skopje
Publisher_xml – name: ID Design 2012/DOOEL Skopje
References 29139
29145
29144
29143
29142
29153
29138
29149
29148
29147
29146
29141
29152
29140
29151
29150
27651273 - J Cyst Fibros. 2017 Mar;16(2):222-229
21793988 - Clin Microbiol Infect. 2012 Mar;18(3):268-81
8994799 - Clin Infect Dis. 1997 Jan;24 Suppl 1:S157-68
25279369 - Front Public Health. 2014 Sep 16;2:145
26439366 - Future Microbiol. 2015;10(10):1683-706
17927473 - Future Microbiol. 2007 Oct;2(5):501-12
16050814 - J Vet Pharmacol Ther. 2005 Aug;28(4):349-54
23845533 - Lancet Infect Dis. 2013 Oct;13(10):867-76
10618060 - J Clin Microbiol. 2000 Jan;38(1):40-3
20014903 - Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93
25798828 - PLoS One. 2015 Mar 23;10(3):e0123690
25556628 - J Intern Med. 2015 May;277(5):501-12
21303394 - FEMS Microbiol Rev. 2011 Sep;35(5):736-55
References_xml – ident: 29147
  doi: 10.1371/journal.pone.0123690
– ident: 29150
  doi: 10.1111/j.1365-2885.2005.00666.x
– ident: 29144
  doi: 10.1111/j.1469-0691.2011.03570.x
– ident: 29148
  doi: 10.1093/clinids/24.Supplement_1.S157
– ident: 29151
  doi: 10.2217/17460913.2.5.501
– ident: 29153
  doi: 10.1016/S1473-3099(13)70168-3
– ident: 29141
  doi: 10.1586/eri.09.108
– ident: 29142
  doi: 10.2217/fmb.15.48
– ident: 29146
  doi: 10.1128/JCM.38.1.40-43.2000
– ident: 29138
  doi: 10.3389/fpubh.2014.00145
– ident: 29139
– ident: 29140
– ident: 29143
  doi: 10.1111/j.1574-6976.2011.00268.x
– ident: 29145
– ident: 29152
  doi: 10.1111/joim.12342
– ident: 29149
  doi: 10.1016/j.jcf.2016.08.005
– reference: 21793988 - Clin Microbiol Infect. 2012 Mar;18(3):268-81
– reference: 23845533 - Lancet Infect Dis. 2013 Oct;13(10):867-76
– reference: 27651273 - J Cyst Fibros. 2017 Mar;16(2):222-229
– reference: 16050814 - J Vet Pharmacol Ther. 2005 Aug;28(4):349-54
– reference: 26439366 - Future Microbiol. 2015;10(10):1683-706
– reference: 25798828 - PLoS One. 2015 Mar 23;10(3):e0123690
– reference: 21303394 - FEMS Microbiol Rev. 2011 Sep;35(5):736-55
– reference: 10618060 - J Clin Microbiol. 2000 Jan;38(1):40-3
– reference: 8994799 - Clin Infect Dis. 1997 Jan;24 Suppl 1:S157-68
– reference: 25279369 - Front Public Health. 2014 Sep 16;2:145
– reference: 17927473 - Future Microbiol. 2007 Oct;2(5):501-12
– reference: 20014903 - Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93
– reference: 25556628 - J Intern Med. 2015 May;277(5):501-12
SSID ssj0001596122
Score 2.0093284
Snippet AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas...
The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs. The...
AIMThe article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 6
SubjectTerms Basic Science
Title Sensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan
URI https://www.ncbi.nlm.nih.gov/pubmed/28293307
https://www.proquest.com/docview/1877853262
https://pubmed.ncbi.nlm.nih.gov/PMC5320898
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELWglRAXBC0fW2hlJA5csjRxHMcHhFalVQFthSgrlVM0sR2a0nXKJisVfkN_dGeS7MJCkbjGsZP42Z43HucNYy-EslpIVQSpMzaI89DgOhjpQCSAbN9AIXPa7xgfJYeT-P2JPPmVDqjvwPpG147ySU1m58PL7z_e4IR_TR5nmupXFUzPpiS9HaohmqDbbB3NUkKe2Ljn-t0vwxqteRv9JPkjnUjZSf3c1MaqlfqLev55gvI3k3Rwn93ruSQfdeA_YLec32B3xn20fJNdHdPp9C49BG8qPvJNOS1b5SWs9nY2_1rzquAfaze3FQ5HqPnI4dXSVzXw_cuG9g6DT64mjukbftzmk6j5OxyvSFEtLz1H_sjHcFbN-CIDSdtmv2nMP8BP-HZK1R-yycH-573DoM--EBiBvCwwYeoSqyxl0EQbb6zVptDkcch01wJEVkhAvicEhA5kbnClygulrMNCUUjxiK35yrsnjIcQh8ruxhAJiCHWgE45ILUXNiK9uGTAhovezkwvTU5fdJ6hi0LwZB08GcGTITwD9nJZ4aJT5fj3rc8X8GU4cygcAt5V8zoLU6WQrERJNGCPOziXjVF8WeDyN2BqBejlDaTKvVriy9NWnZsybaQ63fqP5z5ld-k16UhbKJ-xtWY2d9vIcZp8B9n9l8lOO4KvAS3wADM
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sensitivity+to+Antimicrobial+Drugs+of+Pseudomonas+Aeruginosa+Extreme-Resistant+Strains+Isolated+in+the+Major+Hospitals+of+Central+Kazakhstan&rft.jtitle=Open+access+Macedonian+journal+of+medical+sciences&rft.au=Azizov%2C+Ilya+S&rft.au=Lavrinenko%2C+Alyona+V&rft.au=Belyaev%2C+Ilya+A&rft.au=Babenko%2C+Dmitry+B&rft.date=2017-03-15&rft.issn=1857-9655&rft.eissn=1857-9655&rft.volume=5&rft.issue=1&rft.spage=6&rft.epage=8&rft_id=info:doi/10.3889%2Foamjms.2017.023&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1857-9655&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1857-9655&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1857-9655&client=summon